Physical Sciences & Engineering

No applicants // Limit: 1 // Tickets Available: 1 

UArizona may only submit one Concept Paper and one Full Application for each topic area of this funding program.

The BIL is a once-in-a-generation investment in infrastructure, designed to modernize and upgrade American infrastructure to enhance U.S. competitiveness, driving the creation of good-paying union jobs, tackling theclimate crisis, and ensuring stronger access to economic, environmental, and other benefits for disadvantaged communities (DACs). The BIL appropriates more than $62 billion to the Department of Energy (DOE) including funding to support investments to build a clean and equitable energy economy that achieves zero carbon electricity by 2035, and puts the United States on a path to achieve net-zero emissions economy-wide by no later than 2050“ to benefit all Americans. As new load and generation come online as the market moves in line with these goals, deploying the projects that will support a more resilient and reliable grid will be critical. At present, aging grid infrastructure leaves the grid increasingly vulnerable to attacks. The increasing frequency of extreme weather events is leading to energy supply disruptions that threaten the economy, put public health and safety at risk, and can devastate affected communities all over the country.

This FOA seeks applications to address these three goals:
1. Transform community, regional, interregional, and national resilience, including in consideration of future shifts in generation and load
2. Catalyze and leverage private sector and non-federal public capital for impactful technology and infrastructure deployment
3. Advance community benefits 

No applicants // Limit: 1 // Tickets Available: 1 

This project will build the framework needed to create a neutral and secure data repository and cooperative where producers, universities and not-for-profit entities can store and share data to foster agriculturalinnovation and to support technological progress, production efficiencies, and environmental stewardship. The project must have clear and complete plans to ensure diverse participation, including all land-grant university types, growers, and representatives of all relevant data producer and consumer organizations, with attention to the costs and benefits for all sectors, and with special attention to barriers and value for farmers. 

No applicants // Limit: 1 // Tickets Available: 1 

The Rural Health and Safety Education Program seeks to foster quality of life in rural communities by providing the essential knowledge necessary for successful programs of rural development, improving coordination among Federal agencies, other levels of government, and institutions and private organizations in rural areas, and developing and disseminating information about rural conditions.

Per the authorizing legislation described in Part I (A) of this RFA, the RHSE program addresses the health and well-being of rural America through supporting the development and/or implementation of projects focused on:
1. Individual and family health education programs with specified contents;
2. Rural health leadership development education programs to assist rural communities in developing health care services and facilities and assist community leaders and public officials in understanding their roles and responsibilities; and
3. Farm safety education programs to provide information and training to farm workers, timber harvesters, and farm families.

In FY 2023, NIFA is soliciting applications for RHSE in the area of Individual and Family Health education

The selection process and submission of this funding program are coordinated by the University of Arizona Cancer Center (UACC). For any other questions, please contact UACC Research Development (UACC-PreAward@arizona.edu)
The University of Arizona Cancer Center (UACC) can nominate one applicant for the V Scholar Cancer Research Grant.
 

Purpose of Award:

The UACC is seeking nominations for the V Scholar Cancer Research Grant which supports young tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research.

This RFA is specifically for adult cancer research that is focused on laboratory research. This year, we have special interest and funding for therapeutic resistance and welcome research projects in this area. Please note that research areas not included in this scope are epidemiology, behavioral science, and health services research. We also strongly encourage applications from underrepresented minorities in cancer research including Blacks or African Americans, Hispanics or Latinos (non-European), American Indians or Alaska Natives, Native Hawaiians, and other Pacific Islanders who may be eligible for funding through the Stuart Scott Memorial Cancer Research Fund.

The total amount of the grant is $600,000, paid in three annual installments of $200,000. Only direct costs of the research are supported by this award.

Applicant Eligibility

Inclusion: Nominee must be all of the following criteria by the nomination due date.

• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• Either a US Citizen or a permanent legal resident in the US. This requirement does not apply to invited Canadian institutions.
• Possess at least 2 years post-doctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if only one year is required for their specialty.
• Clinical scientists are eligible if the research institution demonstrates that it will fully support the research applicant (e.g., dedicated lab space, committed research time, start-up funds).
• V Scholar applicants must have been appointed to their first full-time tenure track Assistant Professor position no more than 5 years prior to the nomination due date, and not yet promoted to Associate Professor (for e.g., must be eligible to apply for PI status on an R01 at your institution.

Exclusion: By the Nomination Due Date, nominee must:

• NOT be a previous or current V Foundation V Scholar awardee.
• NOT have accepted or received notification of an R01 award by the nomination due date.
• NOT have accepted or received award notification of any peer-reviewed, non-mentored single grant that totals or exceeds $750K in total direct funding at ANY point in their professional career. This calculation should exclude indirect costs.
• NOT have accepted or received award notification of any peer-reviewed, non-mentored funding that exceeds $1M in aggregated total direct funding at ANY point in their professional career. This calculation should exclude indirect costs.

Note: The V Scholar award is intended to support research to leverage these larger awards; so, the nominee should not have already received such awards.

For any other questions, please contact UACC-PreAward@arizona.edu.

The selection process and submission of this funding program are coordinated by the University of Arizona Cancer Center (UACC). For any other questions, please contact UACC-PreAward@arizona.edu.
The University of Arizona Cancer Center (UACC) can nominate two applicants for the Phi Beta Psi Charity Trust Grant 2023 funding opportunity.

Purpose of Award:

The UACC is seeking nominations for Phi Beta Psi’s Charity Trust Grant 2023. The Phi Beta Psi Sorority is a national, civic, non-profit organization whose National Project is to advance cancer research nationwide to improve prevention, diagnosis, and treatment by providing research grants to qualified investigators addressing original questions and hypotheses to be explored in basic and clinical studies in the field of cancer.

Research applications must be focused on brain, breast, colorectal, endometrial, lung, ovarian, pancreatic, or prostate cancer. Preference is given to Young Investigators with documented evidence of potential for conducting novel research of either basic or clinical aspects of cancer and cancer-related problems. Applications from Established Investigators exploring new and innovative areas of cancer research also will be considered.

Applicant Eligibility:

• Preference is given to Young Investigators with documented evidence of potential for conducting novel research of either basic or clinical aspects of cancer and cancer-related problems.
• Applications from Established Investigators exploring new and innovative areas of cancer research also will be considered.
• Post-doctoral fellows are not eligible.
• Research assistant professors may be eligible.
• The gold standard is as follows: if the individual is eligible to submit an R01 from their institution as Principal Investigator then they are eligible to submit a Phi Beta Psi application.

T. Sawyer (Biomedical Engineering)

The selection process and submission of this funding program are coordinated by the University of Arizona Cancer Center (UACC). For any other questions, please contact UACC Research Development (UACC-PreAward@arizona.edu)

The University of Arizona Cancer Center (UACC) can nominate one applicant for the 2024 Pew-Stewart Scholars Program for Cancer Research which supports assistant professors of outstanding promise in science relevant to the advancement of a cure for cancer.

Purpose of Award:

In line with The Alexander and Margaret Stewart Trust’s mission to invest in innovative, cutting-edge cancer research that may accelerate and advance progress toward a cure for cancer, applications are invited from nominees conducting cancer research. This program is distinct from the Pew Scholars Program, and it follows a different, but parallel set of guidelines and procedures for nominating an applicant whose research is related to cancer.

This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied cancer research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply. Ideas with the potential to produce an unusually high impact are encouraged.

Selection of the successful candidates will be based on a detailed description of the work that the applicant proposes to undertake, evaluations of the candidate’s performance, and notable past accomplishments, including honors, awards, and publications. In evaluating the candidates, the National Advisory Committee gives considerable weight to both the project proposal and the researcher, including evidence that the candidate is a successful independent investigator and has the skill set needed to carry out their high-impact proposal.

Award Terms

An award of $75,000 per year for four years ($300,000 total) will be provided to the sponsoring institution for use by the Pew-Stewart scholar, subject to annual review of his or her progress. Grant agreements will be issued in August of the award year. Funding from the NIH, other government sources, and project grants from nonprofit associations do not pose a conflict with the Pew-Stewart program.

It is expected that Pew-Stewart scholars will spend at least 80 percent of their time in work or activities related to the accomplishment of their overall research goals (which are not restricted to the specific aims proposed for this award). However, Pew provides flexible support to the general research aims of the Pew-Stewart scholar and does not require effort reporting.

The awarded funds may be used at the discretion of the Pew-Stewart scholar, for personnel, equipment, supplies, or travel directly related to the Pew-Stewart scholar's research and as to best advance his or her research and career. Specifically:

• The amount of the award that may be used for the principal investigator’s salary is limited to $12,500 per year (including benefits) or $50,000 over the duration of the grant. There are no limits on student or postdoctoral salaries.
• Not more than 8 percent ($24,000) of the total award value may be allocated for facilities and administration (F&A) charges or indirect costs (IDCs).
• Should the funds not be immediately required, they may be accumulated and carried over through the grant period and, with written approval of the program office, the grant may receive a no-cost extension for one additional year (without additional funds).
• Subawards are allowed.

Funding from the NIH, other government sources, and project grants from nonprofit associations do not pose a conflict with the Pew-Stewart program. If you have questions concerning eligibility, please contact Kara Coleman, project director, Pew Biomedical Programs at 215-575-4925 or Pew-Stewart@pewtrusts.org in advance of applying.

Applicant Eligibility:

Candidates must meet all of the following eligibility requirements:

No applicants.

The selection process and submission of this funding program are coordinated by the University of Arizona Cancer Center (UACC). For any other questions, please contact UACC Research Development (UACC-PreAward@arizona.edu)

The University of Arizona Cancer Center (UACC) can nominate one new (A0) application and one resubmission (A1) application for the NCI Research Specialist (Clinician Scientist) Award funding opportunityper receipt date.

Purpose of Award:

The UACC is seeking nominations for an National Cancer Institute (NCI) Research Specialist Award in any area of NCI-funded clinical cancer research. This FOA is specifically for clinician scientists to continue to participate in the NCI clinical trials networks through leadership in the 1) development of national clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees, and other activities, but not serve as principal investigators of research project grants. These clinician scientists are vital to sustaining the NCI-funded clinical trials enterprise. The Research Specialist Award is intended to provide stable support for clinician scientists at their institutions for significant leadership and exceptional participation in the NCI-sponsored clinical trials networks that conduct cancer treatment, prevention and control, and care delivery clinical trials. NCI-sponsored clinical trials networks include but are not limited to the National Clinical Trials Network (NCTN), the NCI Community Oncology Research Program (NCORP), the Experimental Therapeutics Clinical Trials Network (ETCTN), and the Cancer Prevention Clinical Trials Network (CP-CTNet).

The Research Specialist Award is designed to encourage the development of a career path for cancer clinical trial investigators who provide leadership, participation, and scientific support for the NCI clinical trials networks at their institutions and within those networks. This leadership includes the development of concepts and protocols for clinical trials, participation in scientific steering committees and network committees, and accrual to NCI-sponsored clinical trials. The institutional activities may include the implementation of cancer clinical trials including participation in the review of safety data, monitoring the conduct and progress of open clinical trials, and serving on institutional review committees. These activities are necessary for the successful conduct of NCI-sponsored cancer clinical trials. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others or other sources of funding for cancer research career continuity.

Applicant Eligibility

• Eligible applicants will be clinician scientists who have a clinical degree (M.D., D.O., D.D.S., D.M.D., O.D., D.C., PharmD., N.D., D.V.M.), possess active licensure, and are actively practicing in an oncology clinical setting.
• Individuals with a Ph.D. or other doctoral degree that have direct contact with patients or healthy subjects in clinical disciplines such as clinical psychology, nursing, clinical genetics, speech-language pathology, audiology, or rehabilitation are also eligible.

• At the time of application, the applicant cannot hold as a Principal Investigator current R01, P01, or other significant NIH funding (past funding does not affect eligibility). Support from P50 Career Development awards, R03, R21, P30 funding, or national network funding will be allowed, as long as the total NCI support does not exceed 6 person-months. Future substantial independent NIH funding will require the awardee to forfeit the R50.
• The applicant must be engaged in the conduct of NCI-funded cancer clinical trials research at an academic medical center and have a record of involvement in NCI-funded cancer clinical trial-related activities.
• At the time of application, the Research Specialist must have been at the institution for at least the previous two years.
• The Research Specialist must have a full-time position at the institution.
• The Research Specialist must commit 2.4 to 4.8 person-months to NCI-funded clinical activities during the life of the award. The Research Specialist may engage in other duties as part of the remaining 9.6 to 7.2 person-month effort not covered by this award. The maximum funded effort allowed on all NCI grants, including the R50, will be capped at 6 person-months.
• The Research Specialist must have demonstrated professional accomplishments consonant with his or her career status, and should have demonstrated cancer clinical research experience relevant to the NCI mission.

K. Sierra-Cajas (Undergraduate Research and Inquiry)

The new Beginning for Tribal Students program (NBTS) makes competitive grants to Land-grant Colleges and Universities to provide identifiable support specifically targeted for tribal students. A Land-grant College or University that receives this grant shall use funds for, but not limited to, recruiting; tuition and related fees; experiential learning; student services, including tutoring; counseling; academic advising; and other student services that would increase the retention and graduation rate of tribal students enrolled at the land-grant college or university. The maximum one state can receive is $500,000 per year. 

Limit: 1 //  S. Song (Biomedical Engineering)

The funds are designed to provide to tenure track faculty members in their first to fourth year, at American Institutions, who hold M.D. and/or Ph.D. degrees, start-up support to move the project forward to the point where R01 or other independent funding can be obtained.  Applicants with current R01 funding should not apply.

Beginning in 2023, the grant provides $75,000 annually for a period of up to three years.  Grants are not renewable.  Institutions may submit one proposal per session.  Interested candidates should work through their sponsored projects office.

Proposals must contain an adequately detailed description of the project to be clearly understandable by the scientific members of the Trustees.  They need not be in the detail requested by the NIH for R01 grants and should not exceed five pages in length.  Additional material can be submitted, but the five-page application should contain the essential information.  References should also be included to support the proposal.  Note that the five page limit is only for the project description.  

A one-two page lay summary must be provided as part of the proposal. Applicants should bear in mind that our Board includes non-scientist members, making this summary of particular importance.  The summary should include the project’s title, and the investigator's contact information.

In addition to the institution providing recognition of an internal selection process resulting in no more than one candidate, (this requires just a sentence that may be included in the letters), the proposal must be accompanied by letters of approval by the Dean of the medical school and/or another senior faculty member or members who can represent the support of the institution and who are acquainted with the qualifications of the applicant and the potential impact of his/her work.

S. Mathena (Pediatrics)
One slot is still available.

UArizona may submit two proposals.

The NIH Director's Early Independence Award supports rigorous and promising junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations, are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director's Early Independence Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Eligibility Requirements

Applications with multiple PDs/PIs will not be accepted. Only single PD/PI applications are allowed. Only the PD/PI may be listed as a Senior/Key Person and provide a Biographical Sketch.

U.S. citizenship is not required for PDs/PIs. For applications submitted on behalf of non-U.S. citizens with temporary U.S. visas, visa status must allow the PD/PI to conduct the proposed research at the applicant institution for the entire project period. The applicant institution is responsible for determining if and documenting that the PD's/PI's visa will allow the PD/PI to remain in the U.S. for the duration of the award.

Time window for eligibility: Given the focus on early research independence, the receipt date of the terminal doctoral degree or end of post-graduate clinical training of the PD/PI must be between June 1, 2022, and September 30, 2024. The degree receipt date is that which appears on the official transcript for the degree. The end of post-graduate clinical training includes residency and fellowship periods. The PD/PI must not have served as a post-doctoral fellow for more than 12 months following a previous, non-terminal doctoral degree (i.e., a post-doctoral fellowship served before June 1, 2022).

At the time of award, either 1) the Early Independence investigator must have received a PhD, MD, DO, DC, DDS, DVM, OD, DPM, ScD, EngD, DrPH, DNSc, ND (Doctor of Naturopathy), PharmD, DSW, PsyD, or equivalent doctoral degree from an accredited domestic or foreign institution (it is the responsibility of the sponsoring institution to determine if a foreign doctoral degree is equivalent), or 2) an authorized official of the degree-granting or training institution must certify that all degree requirements have been met and that the receipt date of the degree (as will appear on the transcript) will be before September 30, 2024.  An authorized official of the host institution must certify that the PD/PI will be able to conduct independent research at the institution at the time of the project start date.

Level of effort: In the first and second years of the project period, awardees must commit at least 9.6 person-months of effort to the Early Independence Award project each year (which is 80% effort per year). In years 3-5 of the project period, awardees may reduce their effort on the Early Independence Award project, but they must still conduct at least 9.6 person-months of general independent research each year (which is 80% effort per year). General independent research includes the effort spent on the Early Independence Award project and any other independent research projects the awardee is working on.

Research independence at time of application: Individuals are eligible only if they, at the time of application submission, do not have research independence. Lack of research independence is defined functionally rather than by position title. Eligible individuals must have all the following characteristics:

• The PD/PI's current research agenda is set through concurrence with mentors.
• The PD/PI's research is funded primarily through support to other investigators (mentored fellowships such as NIH F31 or F32 Fellowships or NSF Graduate Research Fellowships do not preclude eligibility).
• The PD/PI does not have any space assigned directly by the institution for the conduct of their research.
• The PD/PI, according to institutional policy, cannot apply for an NIH R01 grant without a special waiver or exemption from the institution.

Though PDs/PIs must not be functionally independent at the time of application submission, they may become functionally independent prior to time of award and still retain eligibility for the award.

Prospective PDs/PIs should contact appropriate institutional leaders to seek an appointment to an independent research position. Alternatively, institutions may actively recruit eligible junior scientists to apply for support through this program. In either case, the institution is expected to provide substantial support for the junior scientist, as detailed below. To foster independence, PDs/PIs may benefit from being hosted by an institution at which they have not previously studied or trained.

PDs/PIs may apply for a research career development (K) award and DP5 at the same time, but NIH policy prohibits scientific and commitment overlap. A PD/PI may not hold a DP5 and career development (K) award concurrently. If the PD/PI receives a career development (K) award, the career development (K) award must be relinquished to receive the DP5.